| Name | 4-methyl-6-nitro-2,3-dihydro-1,4-benzoxazine |
|---|---|
| Synonyms |
4-methyl-6-nitro-3,4-dihydro-2H-benzo[b][1,4]oxazine
4-methyl-6-nitro-3,4-dihydro-2H-1,4-benzoxazine 1-methyl-7-nitro-3,4-dihydro-2H-benzo[1,4]oxazine 4-methyl-6-nitro-3,4-dihydro-2H-benzo[1,4]oxazine 2H-1,4-Benzoxazine,3,4-dihydro-4-methyl-6-nitro 3,4-dihydro-4-methyl-6-nitro-1,4-benzoxazine |
| Molecular Formula | C9H10N2O3 |
|---|---|
| Molecular Weight | 194.18700 |
| Exact Mass | 194.06900 |
| PSA | 58.29000 |
| LogP | 2.01160 |
|
~81%
120711-82-2 |
| Literature: SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH; CHIOSIS, Gabriela; TALDONE, Tony; SUN, Weilin Patent: WO2011/44394 A1, 2011 ; Location in patent: Page/Page column 117-118 ; |
|
~%
120711-82-2 |
| Literature: NEUROGEN CORPORATION Patent: WO2005/23807 A2, 2005 ; Location in patent: Page/Page column 64 ; WO 2005/023807 A2 |
|
~80%
120711-82-2 |
| Literature: Deshmukh, Mahesh S.; Das, Biswajit; Jain, Nidhi RSC Advances, 2013 , vol. 3, # 44 p. 22389 - 22396 |
|
~%
120711-82-2 |
| Literature: Chapleo, Christopher B.; Butler, Richard C. M.; England, David C.; Myers, Peter L.; Roach, Alan G.; et al. Journal of Medicinal Chemistry, 1989 , vol. 32, # 7 p. 1627 - 1630 |
|
~%
120711-82-2 |
| Literature: Chapleo, Christopher B.; Butler, Richard C. M.; England, David C.; Myers, Peter L.; Roach, Alan G.; et al. Journal of Medicinal Chemistry, 1989 , vol. 32, # 7 p. 1627 - 1630 |
|
~%
120711-82-2 |
| Literature: SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH; CHIOSIS, Gabriela; TALDONE, Tony; SUN, Weilin Patent: WO2011/44394 A1, 2011 ; |
| Precursor 7 | |
|---|---|
| DownStream 0 | |